Dopamine reuptake site densities in patients with social phobia

OBJECTIVE: It has been suggested that social phobia is associated with dysfunction of the noradrenergic and dopaminergic systems, but there are no published anatomic data on the monoaminergic abnormalities found in the brains of phobic patients. The authors studied the density of dopamine reuptake s...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of psychiatry Vol. 154; no. 2; pp. 239 - 242
Main Authors TIIHONEN, J, KUIKKA, J, BERGSTRÖM, K, LEPOLA, U, KOPONEN, H, LEINONEN, E
Format Journal Article
LanguageEnglish
Published Washington, DC American Psychiatric Publishing 01.02.1997
American Psychiatric Association
Subjects
Online AccessGet full text

Cover

Loading…
Abstract OBJECTIVE: It has been suggested that social phobia is associated with dysfunction of the noradrenergic and dopaminergic systems, but there are no published anatomic data on the monoaminergic abnormalities found in the brains of phobic patients. The authors studied the density of dopamine reuptake sites in patients with social phobia. METHOD: The study included 11 patients with social phobia and 28 healthy comparison subjects, 11 of whom were age- and gender-matched to the patients for the analyses. Measurement of the density of dopamine reuptake sites was performed by using a 123I-labeled cocaine analogue, [123I]beta-CIT, with single photon emission computed tomography (SPECT). RESULTS: Blind quantitative analysis revealed that striatal dopamine reuptake site densities were markedly lower in the patients with social phobia than in the age- and gender-matched comparison subjects. CONCLUSIONS: The results indicate that social phobia may be associated with a dysfunction of the striatal dopaminergic system.
AbstractList OBJECTIVE: It has been suggested that social phobia is associated with dysfunction of the noradrenergic and dopaminergic systems, but there are no published anatomic data on the monoaminergic abnormalities found in the brains of phobic patients. The authors studied the density of dopamine reuptake sites in patients with social phobia. METHOD: The study included 11 patients with social phobia and 28 healthy comparison subjects, 11 of whom were age- and gender-matched to the patients for the analyses. Measurement of the density of dopamine reuptake sites was performed by using a 123I-labeled cocaine analogue, [123I]beta-CIT, with single photon emission computed tomography (SPECT). RESULTS: Blind quantitative analysis revealed that striatal dopamine reuptake site densities were markedly lower in the patients with social phobia than in the age- and gender-matched comparison subjects. CONCLUSIONS: The results indicate that social phobia may be associated with a dysfunction of the striatal dopaminergic system.
It has been suggested that social phobia is associated with dysfunction of the noradrenergic and dopaminergic systems, but there are no published anatomic data on the monoaminergic abnormalities found in the brains of phobic patients. The authors studied the density of dopamine reuptake sites in patients with social phobia.OBJECTIVEIt has been suggested that social phobia is associated with dysfunction of the noradrenergic and dopaminergic systems, but there are no published anatomic data on the monoaminergic abnormalities found in the brains of phobic patients. The authors studied the density of dopamine reuptake sites in patients with social phobia.The study included 11 patients with social phobia and 28 healthy comparison subjects, 11 of whom were age- and gender-matched to the patients for the analyses. Measurement of the density of dopamine reuptake sites was performed by using a 123I-labeled cocaine analogue, [123I]beta-CIT, with single photon emission computed tomography (SPECT).METHODThe study included 11 patients with social phobia and 28 healthy comparison subjects, 11 of whom were age- and gender-matched to the patients for the analyses. Measurement of the density of dopamine reuptake sites was performed by using a 123I-labeled cocaine analogue, [123I]beta-CIT, with single photon emission computed tomography (SPECT).Blind quantitative analysis revealed that striatal dopamine reuptake site densities were markedly lower in the patients with social phobia than in the age- and gender-matched comparison subjects.RESULTSBlind quantitative analysis revealed that striatal dopamine reuptake site densities were markedly lower in the patients with social phobia than in the age- and gender-matched comparison subjects.The results indicate that social phobia may be associated with a dysfunction of the striatal dopaminergic system.CONCLUSIONSThe results indicate that social phobia may be associated with a dysfunction of the striatal dopaminergic system.
It has been suggested that social phobia is associated with dysfunction of the noradrenergic and dopaminergic systems, but there are no published anatomic data on the monoaminergic abnormalities found in the brains of phobic patients. The authors studied the density of dopamine reuptake sites in patients with social phobia. The study included 11 patients with social phobia and 28 healthy comparison subjects, 11 of whom were age- and gender-matched to the patients for the analyses. Measurement of the density of dopamine reuptake sites was performed by using a 123I-labeled cocaine analogue, [123I]beta-CIT, with single photon emission computed tomography (SPECT). Blind quantitative analysis revealed that striatal dopamine reuptake site densities were markedly lower in the patients with social phobia than in the age- and gender-matched comparison subjects. The results indicate that social phobia may be associated with a dysfunction of the striatal dopaminergic system.
It has been suggested that social phobia is associated with dysfunction of the noradrenergic and dopaminergic systems, but there are no published anatomic data on the monoaminergic abnormalities found in the brains of phobic patients. The authors studied the density of dopamine reuptake sites in patients with social phobia. The study included 11 patients with social phobia and 28 healthy comparison subjects, 11 of whom were age- and gender-matched to the patients for the analyses. Measurement of the density of dopamine reuptake sites was performed by using a 123I-labeled cocaine analogue, [123I]beta-CIT, with single photon emission computed tomography (SPECT). Blind quantitative analysis revealed that striatal dopamine reuptake site densities were markedly lower in the patients with social phobia than in the age- and gender-matched comparison subjects. The results indicate that social phobia may be associated with a dysfunction of the striatal dopaminergic system.
Author TIIHONEN, J
BERGSTRÖM, K
LEPOLA, U
KUIKKA, J
LEINONEN, E
KOPONEN, H
Author_xml – sequence: 1
  givenname: J
  surname: TIIHONEN
  fullname: TIIHONEN, J
  organization: Department of Clinical Psychiatry, University of Kuopio, Finland
– sequence: 2
  givenname: J
  surname: KUIKKA
  fullname: KUIKKA, J
  organization: Department of Clinical Psychiatry, University of Kuopio, Finland
– sequence: 3
  givenname: K
  surname: BERGSTRÖM
  fullname: BERGSTRÖM, K
  organization: Department of Clinical Psychiatry, University of Kuopio, Finland
– sequence: 4
  givenname: U
  surname: LEPOLA
  fullname: LEPOLA, U
  organization: Department of Clinical Psychiatry, University of Kuopio, Finland
– sequence: 5
  givenname: H
  surname: KOPONEN
  fullname: KOPONEN, H
  organization: Department of Clinical Psychiatry, University of Kuopio, Finland
– sequence: 6
  givenname: E
  surname: LEINONEN
  fullname: LEINONEN, E
  organization: Department of Clinical Psychiatry, University of Kuopio, Finland
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2560232$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/9016274$$D View this record in MEDLINE/PubMed
BookMark eNp1kc2LFDEQxYOsrLOrR49Co-JB6DGVj073SWT9hAUvCt5CdXc1m7EniUk34n9vhhkWWdxTJbzfq6rkXbAzHzwx9hT4FsA0b3AXt6DVVmyF7B6wDWipayNEe8Y2nHNRd1r-eMQuct6VK5dGnLPzjkMjjNqwt-9DxL3zVCVa44I_qcpuoWokX6qjXDlfRSwnv-Tqt1tuqhwGh3MVb0Lv8DF7OOGc6cmpXrLvHz98u_pcX3_99OXq3XWNipulBoU0QNtNBJM2PZQteg4GemmUHFpq2r5TuqhjY3hxQIM0Ao6kJYytVPKSvTr2jSn8Wikvdu_yQPOMnsKarWlb4J0yBXx-B9yFNfmymxWCF0A1okAv7oNAQytF17UH6tmJWvs9jTYmt8f0x54-r-gvTzrmAecpoR9cvsWEbriQhzb1ERtSyDnRdEsAt4cIbYmwzFVW2BJh4eUdfnBLSSD4JaGb73W9ProwRvfPc_4L_wVSvapq
CODEN AJPSAO
CitedBy_id crossref_primary_10_1016_S0165_1781_98_00117_6
crossref_primary_10_1016_j_sjpain_2011_06_004
crossref_primary_10_1176_appi_ajp_160_5_904
crossref_primary_10_1016_j_neuropharm_2018_12_016
crossref_primary_10_1016_j_janxdis_2010_02_002
crossref_primary_10_1111_j_1749_6632_2003_tb07095_x
crossref_primary_10_1016_j_pnpbp_2007_06_027
crossref_primary_10_3389_fnins_2020_00154
crossref_primary_10_1016_j_neuroscience_2023_09_008
crossref_primary_10_1016_S0165_0327_98_00094_9
crossref_primary_10_1034_j_1600_0447_2001_00090_x
crossref_primary_10_1016_S0014_2999_03_01275_5
crossref_primary_10_1016_j_bbr_2009_06_009
crossref_primary_10_1016_j_cpr_2006_12_003
crossref_primary_10_1017_S0033291717001076
crossref_primary_10_1177_1073191116654003
crossref_primary_10_1038_s41398_023_02708_8
crossref_primary_10_1177_0269881112450778
crossref_primary_10_1016_j_jns_2016_12_062
crossref_primary_10_1016_S1077_7229_01_80005_5
crossref_primary_10_1016_j_cpet_2007_09_005
crossref_primary_10_1016_S0306_4522_03_00032_0
crossref_primary_10_5694_j_1326_5377_1998_tb126710_x
crossref_primary_10_1016_j_pain_2012_01_002
crossref_primary_10_1176_appi_ajp_158_2_327_a
crossref_primary_10_1016_j_comppsych_2017_12_002
crossref_primary_10_1016_S0013_7006_04_95442_5
crossref_primary_10_1177_2045125317714193
crossref_primary_10_1016_j_jpsychires_2009_04_014
crossref_primary_10_1016_j_pnpbp_2014_12_008
crossref_primary_10_1016_j_nicl_2017_08_001
crossref_primary_10_1590_S0100_879X2002000800013
crossref_primary_10_1002_syn_20746
crossref_primary_10_1017_S1092852900027267
crossref_primary_10_1016_S0006_3223_01_01268_9
crossref_primary_10_1034_j_1600_0447_108_s417_4_x
crossref_primary_10_1017_S0954579413000941
crossref_primary_10_1016_j_bbr_2018_10_028
crossref_primary_10_1016_j_pscychresns_2006_03_001
crossref_primary_10_1016_S0006_3223_98_00265_0
crossref_primary_10_1016_j_bbr_2008_08_047
crossref_primary_10_1016_j_yhbeh_2011_08_013
crossref_primary_10_1016_S0301_0082_03_00087_X
crossref_primary_10_1016_j_pnpbp_2010_02_028
crossref_primary_10_1002_da_20543
crossref_primary_10_1016_j_neurobiolaging_2017_05_006
crossref_primary_10_1016_j_pscychresns_2009_04_006
crossref_primary_10_1177_0269881108098144
crossref_primary_10_1016_S0278_5846_99_00109_8
crossref_primary_10_1177_0003065109333502
crossref_primary_10_2967_jnumed_107_045518
crossref_primary_10_1016_j_pnpbp_2007_04_020
crossref_primary_10_1017_S1092852900028066
crossref_primary_10_1093_scan_nsw149
crossref_primary_10_1176_jnp_14_4_438
crossref_primary_10_1016_j_neulet_2019_134443
crossref_primary_10_1016_j_yebeh_2014_01_001
crossref_primary_10_2967_jnumed_118_212795
crossref_primary_10_1016_S0160_2527_00_00059_5
crossref_primary_10_1073_pnas_1518825113
crossref_primary_10_1017_S109285291400008X
crossref_primary_10_1111_spc3_12515
crossref_primary_10_1067_mai_2001_114798
crossref_primary_10_1017_S1092852900010361
crossref_primary_10_1017_S1092852900015534
crossref_primary_10_1111_j_1528_1157_1999_tb00935_x
crossref_primary_10_1111_j_1742_7843_2007_00145_x
crossref_primary_10_1176_appi_ajp_157_5_834_a
crossref_primary_10_1038_s41398_022_02187_3
crossref_primary_10_1016_j_baga_2012_06_004
crossref_primary_10_1034_j_1600_0447_2001_0008a_x
crossref_primary_10_19127_mbsjohs_676960
crossref_primary_10_1002__SICI_1098_2396_199803_28_3_244__AID_SYN7_3_0_CO_2_A
crossref_primary_10_1371_journal_pone_0017405
crossref_primary_10_1176_appi_ajp_157_3_457
crossref_primary_10_1016_j_comppsych_2012_03_002
crossref_primary_10_1016_S0193_953X_02_00018_7
crossref_primary_10_1016_j_neuroscience_2019_07_026
crossref_primary_10_1016_j_jns_2011_06_056
crossref_primary_10_1590_1516_4446_2021_1926
crossref_primary_10_1016_j_euroneuro_2017_03_007
crossref_primary_10_1017_S1092852900012499
crossref_primary_10_1176_appi_ajp_158_10_1558
crossref_primary_10_1080_10673220600748536
crossref_primary_10_1016_j_biopsych_2006_05_043
crossref_primary_10_1016_S0165_1781_02_00103_8
crossref_primary_10_3389_fnins_2020_608520
crossref_primary_10_1016_S0165_0327_99_00140_8
crossref_primary_10_1111_j_1749_6632_2003_tb07096_x
crossref_primary_10_1517_13543776_13_4_401
crossref_primary_10_1126_science_1120972
crossref_primary_10_3109_07853899809005851
crossref_primary_10_1002_jnr_21642
crossref_primary_10_1016_j_nic_2006_06_003
crossref_primary_10_1093_scan_nst129
crossref_primary_10_1176_foc_9_3_foc311
crossref_primary_10_1016_S0025_7125_05_70337_0
crossref_primary_10_31363_2313_7053_2019_2_3_12
crossref_primary_10_1515_revneuro_2018_0037
crossref_primary_10_1016_S0140_6736_08_60488_2
crossref_primary_10_1590_S1516_44462002000100012
crossref_primary_10_1017_S1092852900021635
crossref_primary_10_1523_JNEUROSCI_2382_18_2019
crossref_primary_10_1016_j_bbrc_2018_03_162
crossref_primary_10_1016_S0193_953X_05_70259_8
crossref_primary_10_1016_j_psychres_2005_05_004
crossref_primary_10_1016_j_neubiorev_2011_08_002
crossref_primary_10_1016_S0025_7125_05_70329_1
crossref_primary_10_1176_appi_ajp_161_1_59
crossref_primary_10_1007_s00018_020_03649_x
Cites_doi 10.1002/syn.890160203
10.1016/0278-5846(92)90020-F
10.1097/00006231-199306000-00013
10.1038/ng0196-78
10.1007/BF00941852
10.1016/0166-2236(92)90068-J
10.1001/archpsyc.1994.03950120047008
10.1038/ng0196-81
10.1001/archpsyc.1994.03950080019003
10.1176/ajp.138.12.1572
10.1001/archpsyc.1994.03950010008002
10.1007/BF01245007
10.1007/BF00182306
10.1097/00004714-198604000-00006
10.1097/00004714-198808000-00008
10.1038/nm0795-654
10.1038/jcbfm.1993.39
10.1192/bjp.161.3.353
10.1001/archpsyc.1984.01790210041006
10.1073/pnas.90.24.11965
10.1037/e591322011-001
10.1016/1353-8020(95)00012-U
10.1007/BF00180909
ContentType Journal Article
Copyright 1997 INIST-CNRS
Copyright American Psychiatric Association Feb 1997
Copyright_xml – notice: 1997 INIST-CNRS
– notice: Copyright American Psychiatric Association Feb 1997
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
HAWNG
HBMBR
IBDFT
K30
PAAUG
PAWHS
PAWZZ
PAXOH
PBHAV
PBQSW
PBYQZ
PCIWU
PCMID
PCZJX
PDGRG
PDWWI
PETMR
PFVGT
PGXDX
PIHIL
PISVA
PJCTQ
PJTMS
PLCHJ
PMHAD
PNQDJ
POUND
PPLAD
PQAPC
PQCAN
PQCMW
PQEME
PQHKH
PQMID
PQNCT
PQNET
PQSCT
PQSET
PSVJG
PVMQY
PZGFC
K9.
NAPCQ
7X8
DOI 10.1176/ajp.154.2.239
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Periodicals Index Online Segment 13
Periodicals Index Online Segment 14
Periodicals Index Online Segment 27
Periodicals Index Online
Primary Sources Access—Foundation Edition (Plan E) - West
Primary Sources Access (Plan D) - International
Primary Sources Access & Build (Plan A) - MEA
Primary Sources Access—Foundation Edition (Plan E) - Midwest
Primary Sources Access—Foundation Edition (Plan E) - Northeast
Primary Sources Access (Plan D) - Southeast
Primary Sources Access (Plan D) - North Central
Primary Sources Access—Foundation Edition (Plan E) - Southeast
Primary Sources Access (Plan D) - South Central
Primary Sources Access & Build (Plan A) - UK / I
Primary Sources Access (Plan D) - Canada
Primary Sources Access (Plan D) - EMEALA
Primary Sources Access—Foundation Edition (Plan E) - North Central
Primary Sources Access—Foundation Edition (Plan E) - South Central
Primary Sources Access & Build (Plan A) - International
Primary Sources Access—Foundation Edition (Plan E) - International
Primary Sources Access (Plan D) - West
Periodicals Index Online Segments 1-50
Primary Sources Access (Plan D) - APAC
Primary Sources Access (Plan D) - Midwest
Primary Sources Access (Plan D) - MEA
Primary Sources Access—Foundation Edition (Plan E) - Canada
Primary Sources Access—Foundation Edition (Plan E) - UK / I
Primary Sources Access—Foundation Edition (Plan E) - EMEALA
Primary Sources Access & Build (Plan A) - APAC
Primary Sources Access & Build (Plan A) - Canada
Primary Sources Access & Build (Plan A) - West
Primary Sources Access & Build (Plan A) - EMEALA
Primary Sources Access (Plan D) - Northeast
Primary Sources Access & Build (Plan A) - Midwest
Primary Sources Access & Build (Plan A) - North Central
Primary Sources Access & Build (Plan A) - Northeast
Primary Sources Access & Build (Plan A) - South Central
Primary Sources Access & Build (Plan A) - Southeast
Primary Sources Access (Plan D) - UK / I
Primary Sources Access—Foundation Edition (Plan E) - APAC
Primary Sources Access—Foundation Edition (Plan E) - MEA
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Periodicals Index Online Segment 14
Periodicals Index Online Segments 1-50
Periodicals Index Online Segment 27
Periodicals Index Online
Periodicals Index Online Segment 13
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1535-7228
EndPage 242
ExternalDocumentID 11056542
9016274
2560232
10_1176_ajp_154_2_239
10.1176/ajp.154.2.239
Genre Journal Article
GroupedDBID ---
--Z
-DZ
-~X
.55
.GJ
08R
0WA
1HT
1KJ
1QT
23M
2WC
3O-
4.4
53G
5GY
5RE
6J9
7K8
85S
8R4
8R5
AAAHA
AAIKC
AAJWC
AAMNW
AAPBV
AAWTL
AAWTO
ABFLS
ABIVO
ABPPZ
ABPTK
ABZEH
ACBMB
ACGFO
ACGOD
ACHQT
ACNCT
ADBBV
ADCOW
ADMHG
AENEX
AETEA
AFAZI
AFFNX
AFMIJ
AFOSN
AGNAY
AHMBA
AI.
AJKYJ
ALMA_UNASSIGNED_HOLDINGS
ASUFR
BAJDF
BAWUL
BENPR
BKOMP
CS3
DIK
E3Z
EBS
EJD
EX3
F20
F5P
F8P
FA8
FJW
G0H
G8K
H13
HF~
HZ~
J5H
L7B
MVM
N4W
N9A
NEJ
NHB
OHT
OK1
OVD
P-O
P2P
PQEST
PQQKQ
Q.-
Q2X
RAY
RXW
RYA
S10
SJN
SKT
TAE
TEORI
TR2
TWZ
UHB
UKR
ULE
UPT
UQL
VH1
VVN
WH7
WHG
WOQ
WOW
X4V
X6Y
X7M
XJT
XOL
XSW
XZL
YCJ
YFH
YOC
YWH
YZZ
ZA5
ZCA
ZGI
ZHY
ZRR
ZXP
ZY1
~A~
~G0
AAJMC
AAYXX
ABDPE
AGHSJ
CITATION
08P
1CY
2QL
354
41~
6TJ
8F7
AAKAS
AAQQT
AAUGY
AAYJJ
ADZCM
AERZD
AFFDN
AHJKT
AKALU
BCR
BLC
GOZPB
GRPMH
IQODW
LXL
LXN
PEA
RWL
UBC
YQI
YQJ
YRY
YSK
YXB
YYQ
ZKB
~X8
AIZTS
CGR
CUY
CVF
ECM
EIF
LPU
NPM
VXZ
YIF
YIN
Z5M
HAWNG
HBMBR
IBDFT
K30
PAAUG
PAWHS
PAWZZ
PAXOH
PBHAV
PBQSW
PBYQZ
PCIWU
PCMID
PCZJX
PDGRG
PDWWI
PETMR
PFVGT
PGXDX
PIHIL
PISVA
PJCTQ
PJTMS
PLCHJ
PMHAD
PNQDJ
POUND
PPLAD
PQAPC
PQCAN
PQCMW
PQEME
PQHKH
PQMID
PQNCT
PQNET
PQSCT
PQSET
PSVJG
PVMQY
PZGFC
ADXHL
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-a407t-14aec189fe1f57b1372b0171b3743c8e68b945fe1d67040716aed1ade531d8343
ISSN 0002-953X
IngestDate Thu Jul 10 20:02:29 EDT 2025
Tue Aug 12 03:55:02 EDT 2025
Mon Jun 30 16:00:48 EDT 2025
Wed Feb 19 01:23:52 EST 2025
Sun Oct 22 16:04:27 EDT 2023
Thu Apr 24 23:12:24 EDT 2025
Tue Jul 01 04:08:59 EDT 2025
Fri Oct 28 07:32:04 EDT 2022
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Human
Dopamine
Reuptake site
Social phobia
Central nervous system
Anxiety disorder
Neurotransmitter
Corpus striatum
Brain (vertebrata)
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-a407t-14aec189fe1f57b1372b0171b3743c8e68b945fe1d67040716aed1ade531d8343
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
PMID 9016274
PQID 1518329982
PQPubID 1816671
PageCount 4
ParticipantIDs proquest_miscellaneous_78810947
proquest_journals_220473462
proquest_journals_1518329982
pubmed_primary_9016274
pascalfrancis_primary_2560232
crossref_primary_10_1176_ajp_154_2_239
crossref_citationtrail_10_1176_ajp_154_2_239
appi_journals_10_1176_ajp_154_2_239
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1997-02-01
PublicationDateYYYYMMDD 1997-02-01
PublicationDate_xml – month: 02
  year: 1997
  text: 1997-02-01
  day: 01
PublicationDecade 1990
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
– name: United States
– name: Washington, D.C
– name: Washington
PublicationTitle The American journal of psychiatry
PublicationTitleAlternate Am J Psychiatry
PublicationYear 1997
Publisher American Psychiatric Publishing
American Psychiatric Association
Publisher_xml – name: American Psychiatric Publishing
– name: American Psychiatric Association
References p_28
p_29
p_23
p_24
p_25
p_26
Bandecchi A (p_27) 1994; 10
p_20
p_21
p_16
p_17
p_18
p_1
p_19
p_4
p_3
p_13
p_6
p_14
p_15
p_7
p_9
Cloninger (p_12) 1994
Bergström KA (p_22) 1994; 38
Liebowitz MR (p_8) 1988; 49
Stein MB (p_2) 1994; 152
p_10
Uhde TW (p_5) 1991; 52
p_11
11156831 - Am J Psychiatry. 2001 Feb;158(2):327-8
References_xml – ident: p_17
  doi: 10.1002/syn.890160203
– ident: p_11
  doi: 10.1016/0278-5846(92)90020-F
– ident: p_21
  doi: 10.1097/00006231-199306000-00013
– ident: p_13
  doi: 10.1038/ng0196-78
– ident: p_23
  doi: 10.1007/BF00941852
– ident: p_15
  doi: 10.1016/0166-2236(92)90068-J
– volume: 152
  start-page: 408
  year: 1994
  ident: p_2
  publication-title: Am J Psychiatry
– ident: p_4
  doi: 10.1001/archpsyc.1994.03950120047008
– volume: 52
  start-page: 31
  year: 1991
  ident: p_5
  publication-title: J Clin Psychiatry
– ident: p_14
  doi: 10.1038/ng0196-81
– ident: p_29
  doi: 10.1001/archpsyc.1994.03950080019003
– ident: p_10
  doi: 10.1176/ajp.138.12.1572
– volume: 38
  start-page: 128
  year: 1994
  ident: p_22
  publication-title: J Nucl Biol Med
– ident: p_3
  doi: 10.1001/archpsyc.1994.03950010008002
– ident: p_18
  doi: 10.1007/BF01245007
– ident: p_20
  doi: 10.1007/BF00182306
– ident: p_6
  doi: 10.1097/00004714-198604000-00006
– ident: p_7
  doi: 10.1097/00004714-198808000-00008
– ident: p_24
  doi: 10.1038/nm0795-654
– volume: 49
  start-page: 252
  year: 1988
  ident: p_8
  publication-title: J Clin Psychiatry
– ident: p_28
  doi: 10.1038/jcbfm.1993.39
– ident: p_9
  doi: 10.1192/bjp.161.3.353
– ident: p_1
  doi: 10.1001/archpsyc.1984.01790210041006
– ident: p_19
  doi: 10.1073/pnas.90.24.11965
– ident: p_26
  doi: 10.1037/e591322011-001
– ident: p_25
  doi: 10.1016/1353-8020(95)00012-U
– ident: p_16
  doi: 10.1007/BF00180909
– volume-title: The Temperament and Character Inventory (TCI): A Guide to its Development and Use. St Louis
  year: 1994
  ident: p_12
– volume: 10
  start-page: 725S
  year: 1994
  ident: p_27
  publication-title: Neuropsychopharmacology
– reference: 11156831 - Am J Psychiatry. 2001 Feb;158(2):327-8
SSID ssj0000372
Score 1.9985242
Snippet OBJECTIVE: It has been suggested that social phobia is associated with dysfunction of the noradrenergic and dopaminergic systems, but there are no published...
It has been suggested that social phobia is associated with dysfunction of the noradrenergic and dopaminergic systems, but there are no published anatomic data...
SourceID proquest
pubmed
pascalfrancis
crossref
appi
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 239
SubjectTerms Adult
Adult and adolescent clinical studies
Aged
Anxiety disorders. Neuroses
Biological and medical sciences
Brain
Brain - diagnostic imaging
Brain Chemistry
Carrier Proteins - metabolism
Cocaine - analogs & derivatives
Corpus Striatum - chemistry
Corpus Striatum - diagnostic imaging
Dopamine - analysis
Dopamine Plasma Membrane Transport Proteins
Dopamine Uptake Inhibitors - therapeutic use
Fear & phobias
Female
Humans
Male
Medical sciences
Membrane Glycoproteins
Membrane Transport Proteins
Middle Aged
Nerve Tissue Proteins
Neurology
Neurons
Phobia
Phobic Disorders - diagnosis
Phobic Disorders - diagnostic imaging
Psychiatry
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Tomography, Emission-Computed, Single-Photon
Title Dopamine reuptake site densities in patients with social phobia
URI http://dx.doi.org/10.1176/ajp.154.2.239
https://www.ncbi.nlm.nih.gov/pubmed/9016274
https://www.proquest.com/docview/1518329982
https://www.proquest.com/docview/220473462
https://www.proquest.com/docview/78810947
Volume 154
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgSAgJIW4T3QUsgXgZHc3VzhPaGGhjl0bQSttT5CQOzbqlUZM-wK_n-JY0KkXAS1TZruP4fD4-xz4XhN4MaOqwxI_7wksTHiDDBZkgCAtoHPA4ITJbw_mFfzx2v1x6l60pr_QuqeP95Odv_Ur-h6pQBnQVXrL_QNmmUyiA30BfeAKF4flXND4CjfdWiIlf-aKs2ZTvfQMJEnhIUclAqeIwI1SBU4Wdaz3Z09644WQW52xZMB21HibFcjiJrjW0MtjNJ7NC-3SApt1eBuXTqbK8_TGfNsWHfP69quWF_KEvwXea35rKMxD_b-R_xir5kT6BUNFbu9YcZnChGVGerICrZb-BJxMAt-xXBZHWOLOXmakKc7TK5ImMbnxdqmOxfd2uG0w7PBhG4ckwGl6cXd1F92zQIkSCi6OT03ajdohttCMxKhOClfjvO53Dbs3KMu9ILg9LVsEiylT2k_XqiRRTRo_RI61f4AMFlifoDi-eovvn2oLiGfpgMIMNZrDADG4wg_MCG8xggRmsMIMVZp6j8edPo4_HfZ1Eo89AV6_7lst4YtEg41bmkdiCb45FjKTYAdkxodyHJel6UJv6ZCC0e5_x1GIpB-acUsd1NtFGAah6gbBDszT2SEJBpXATEGpcK01JRjMCPVKP9NBrMU-RBmkVSQWT-BHMZgSzGdkRzGYPvTPTGCU6Dr1Ih3KzrvnbpnmpArCsa7jboUnTWgj1oDf00I6h0dIIPbGlBQGF6u3VatseuMRxfah91dQC_xWXaqzgs0UViXQMg8CFj99UdG_eC5K2SGy19ef3bqMH7ZraQRv1fMF3Qc6t45cSrb8A0PGnCg
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dopamine+Reuptake+Site+Densities+in+Patients+With+Social+Phobia&rft.jtitle=The+American+journal+of+psychiatry&rft.au=Tiihonen%2C+Jari&rft.au=Kuikka%2C+Jyrki&rft.au=Bergstr%C3%B6m%2C+Kim&rft.au=Lepola%2C+Ulla&rft.date=1997-02-01&rft.pub=American+Psychiatric+Association&rft.issn=0002-953X&rft.volume=154&rft.issue=2&rft.spage=239&rft_id=info:doi/10.1176%2Fajp.154.2.239&rft.externalDBID=PAO_PIO_ONLY
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-953X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-953X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-953X&client=summon